Join us in this series on topics and trends taking place in Canada’s rapidly transforming life sciences ecosystem. Industry players, investors, and advisors on both sides of the Canada-U.S. border will want to join our interdisciplinary team for discussions on where the sector in Canada is headed—from product liability claim strategy and drug pricing to procurement, biometrics and more.
The price is right: where is drug pricing headed in Canada?
Our team will discuss emerging trends in drug pricing—including shifting dynamics between Canada’s drug pricing regulator, the PMPRB, and Canadian courts—and what the potential implications are for both regulatory, litigation and broader business strategies for companies in the life sciences sector.
Ontario: This program is eligible for 60 Substantive minutes. New York: This program contains 1.0 Areas of Professional Practice credit. This course content is appropriate for transitional and non-transitional attorneys.